Stay updated with breaking news from Britain Eakin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A Federal Circuit panel seemed skeptical Tuesday that Gilead Sciences and Astellas were wrongly barred from responding to amendments Hospira made "at the eleventh hour" to an abbreviated new drug application to skirt infringement of patents on cardiac stress agent Lexiscan.
A begrudging California federal judge is giving a Mexican restaurant another shot at a proposed Lanham Act class action against Google, but warned the restaurant's attorneys that sanctions could be on the horizon over misleading evidence in the first amended complaint.
In the latest installment of the battle over who invented gene editing technology CRISPR first, chemical giant Sigma-Aldrich urged the Patent Trial and Appeal Board on Monday to recognize that its contribution to the field sets it apart.
The Federal Circuit on Wednesday backed the claim construction behind the Patent Trial and Appeal Board's invalidation of three CUPP Computing cybersecurity patents in challenges from Trend Micro, clarifying that disclaimers made during inter partes reviews only apply in subsequent proceedings.
A federal jury in the Western District of Texas on Tuesday hit Intel Corp. with a nearly $949 million verdict for infringing a VLSI patent for microchip technology, handing the patent licensing company another whopping verdict in its ongoing fight with the chipmaker.